These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology. Agid O; Lerer B J Clin Psychiatry; 1999 Jan; 60(1):55-6. PubMed ID: 10074882 [No Abstract] [Full Text] [Related]
5. Obsessive-compulsive spectrum disorders: effective treatment with paroxetine. Ravindran AV; Lapierre YD; Anisman H Can J Psychiatry; 1999 Oct; 44(8):805-7. PubMed ID: 10566112 [TBL] [Abstract][Full Text] [Related]
6. Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine. Brody AL; Saxena S; Fairbanks LA; Alborzian S; Demaree HA; Maidment KM; Baxter LR J Clin Psychiatry; 2000 May; 61(5):349-55. PubMed ID: 10847309 [TBL] [Abstract][Full Text] [Related]
7. Paroxetine for treatment of obsessive-compulsive disorder and comorbid stuttering. Murray MG; Newman RM Am J Psychiatry; 1997 Jul; 154(7):1037. PubMed ID: 9210761 [No Abstract] [Full Text] [Related]
8. Paroxetine and irritable bowel syndrome. Kirsch MA; Louie AK Am J Psychiatry; 2000 Sep; 157(9):1523-4. PubMed ID: 10964877 [No Abstract] [Full Text] [Related]
9. Do compulsive buyers and kleptomaniacs share identical characteristics? Fishbain DA J Clin Psychiatry; 1994 Dec; 55(12):545-6. PubMed ID: 7814354 [No Abstract] [Full Text] [Related]
10. [Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia]. Scholl HP; Kasper S; Danos P; Höflich G; Möller HJ Nervenarzt; 1994 Jul; 65(7):478-81. PubMed ID: 7800092 [TBL] [Abstract][Full Text] [Related]
11. Re: A treatment for impulse control disorders. Fedoroff JP Can J Psychiatry; 1995 Aug; 40(6):361. PubMed ID: 7585409 [No Abstract] [Full Text] [Related]
12. Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features. Strous RD; Patel JK; Zimmet S; Green AI Am J Psychiatry; 1999 Jun; 156(6):973-4. PubMed ID: 10360153 [No Abstract] [Full Text] [Related]
13. Pathological hoarding. Jefferys D; Moore KA Aust Fam Physician; 2008 Apr; 37(4):237-41. PubMed ID: 18398520 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of comorbid obsessive-compulsive and depressive disorders in children age]. Goriunov AV; Lobacheva MV Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11 Pt 2):48-52. PubMed ID: 23257756 [TBL] [Abstract][Full Text] [Related]
15. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials? Geller DA; Biederman J; Stewart SE; Mullin B; Farrell C; Wagner KD; Emslie G; Carpenter D J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S19-29. PubMed ID: 12880497 [TBL] [Abstract][Full Text] [Related]
16. Emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitors. Kindler S; Dannon PN; Iancu I; Sasson Y; Zohar J Clin Neuropharmacol; 1997 Apr; 20(2):126-9. PubMed ID: 9099464 [TBL] [Abstract][Full Text] [Related]
17. Impulse control disorders in patients with obsessive-compulsive disorder. Fontenelle LF; Mendlowicz MV; Versiani M Psychiatry Clin Neurosci; 2005 Feb; 59(1):30-7. PubMed ID: 15679537 [TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitors and delusional depression. Rothschild AJ; Phillips KA Am J Psychiatry; 1999 Jun; 156(6):977-8. PubMed ID: 10360159 [No Abstract] [Full Text] [Related]
19. Paroxetine-induced anorexia in a patient with bulimia nervosa. Sagduyu K J Clin Psychiatry; 1997 May; 58(5):220-1. PubMed ID: 9184619 [No Abstract] [Full Text] [Related]
20. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Pigott TA; Seay SM J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]